NEURELIS, INC.

Lobbying client · California · filed 2025 to 2026

Biopharmaceutical company specializing in treatments for neurological conditions.

$60,000 Reported spend

6 Filings counted

1 Firms hired

5 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (61903), not by name.

Firms hired 1

ARNOLD & PORTER KAYE SCHOLER LLP $60,000 6 filings

Bills named in these filings 5

S 1214
RARE Act

3 filings
HR 7383
RARE Act

2 filings
HR 1262
Mikaela Naylon Give Kids a Chance Act

2 filings
S 932
Give Kids a Chance Act of 2025

2 filings
HR 7383
Improving Access to Health Care in Rural and Underserved Areas Act

1 filing

Reported by year 2 years

2026 $10,000 2 filings
2025 $50,000 4 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 6 total

Q2Y

ARNOLD & PORTER KAYE SCHOLER LLP

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 17, 2026

View → Q1

ARNOLD & PORTER KAYE SCHOLER LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 17, 2026

View → Q4Y

ARNOLD & PORTER KAYE SCHOLER LLP

4th Quarter (Oct 1 - Dec 31) 2025 · posted Jan 14, 2026

View → Q3Y

ARNOLD & PORTER KAYE SCHOLER LLP

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 20, 2025

View → Q2

ARNOLD & PORTER KAYE SCHOLER LLP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 18, 2025

View → Q1

ARNOLD & PORTER KAYE SCHOLER LLP

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $40,000 income · posted Apr 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.